Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function

Clinical trial NCT00972374 · COMPLETED

Trial details

NCT number: NCT00972374
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rhegmatogenous Macula-off Retinal Detachment

Start date: 2009-11-01
Primary completion: 2010-10-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.